1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Szolajska, E.
Poznanski, J.
Ferber, M.L.
Michalik, J.
Gout, E.
Fender, P.
Bailly, I.
Dublet, B.
Chroboczek, J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
271
2127
2136
10.1111/j.1432-1033.2004.04128.x
15153103
Poneratoxin, a neurotoxin from ant venom. Structure and expression in insect cells and construction of a bio-insecticide.
2004
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
2759.355
PONERATOXIN
1
syn
polymer
PAC-TX
no
no
FLPLLILGSLLMTPPVIQAIHDAQR
FLPLLILGSLLMTPPVIQAIHDAQR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
repository
Initial release
Version format compliance
Version format compliance
1
0
2003-11-18
1
1
2008-04-27
1
2
2011-07-13
RCSB
Y
RCSB
2000-11-22
REL
REL
The peptide was chemically synthesized. The sequence of the peptide is naturally found in Paraponera clavata (Venon ant).
sample
This structure was determined using standard 2D homonuclear techniques. 100 and 200 ms mixing time 2D-NOESY spectra were accumulated
target function
333
10
DQF-COSY
2D NOESY
TOCSY
5.5
1
atm
298
K
The structures are based on 428 NOE-derived distance restraints and 20 dihedral angle restraints.
Simulated annealing in the REDAC strategy made by DYANA.
Final refinement, inculding PRO pyrrolidine ring puckering by X-PLOR.
simulated annealing
1
lowest energy
3 mM of C-amidated peptide
D2O:TFE in volumetric ratio 3:1
Bruker
collection
UXNMR
930601.3
Delaglio, Grzesiek, Vuister, Zhu, Pfeifer, Bax
processing
NMRPipe
1.7
Bartels, Xia, Guntert, Billeter, Wuthrich
data analysis
XEasy
1.3.11
Guntert, Mumenthaler
structure solution
DYANA
1.5
Brunger
refinement
X-PLOR
3.1
Biosym
data analysis
SYBYL
6.5
600
Bruker
AMX
PHE
1
n
1
PHE
1
A
LEU
2
n
2
LEU
2
A
PRO
3
n
3
PRO
3
A
LEU
4
n
4
LEU
4
A
LEU
5
n
5
LEU
5
A
ILE
6
n
6
ILE
6
A
LEU
7
n
7
LEU
7
A
GLY
8
n
8
GLY
8
A
SER
9
n
9
SER
9
A
LEU
10
n
10
LEU
10
A
LEU
11
n
11
LEU
11
A
MET
12
n
12
MET
12
A
THR
13
n
13
THR
13
A
PRO
14
n
14
PRO
14
A
PRO
15
n
15
PRO
15
A
VAL
16
n
16
VAL
16
A
ILE
17
n
17
ILE
17
A
GLN
18
n
18
GLN
18
A
ALA
19
n
19
ALA
19
A
ILE
20
n
20
ILE
20
A
HIS
21
n
21
HIS
21
A
ASP
22
n
22
ASP
22
A
ALA
23
n
23
ALA
23
A
GLN
24
n
24
GLN
24
A
ARG
25
n
25
ARG
25
A
1
A
A
O
H
PHE
LEU
1
5
1.16
1
A
A
HA
HD21
PHE
LEU
1
5
1.33
1
A
A
O
H
VAL
GLN
16
18
1.57
1
A
A
OD1
NH2
ASP
ARG
22
25
2.06
1
A
A
CD1
OE1
LEU
GLN
2
18
2.12
1
A
A
O
N
PHE
LEU
1
5
2.15
2
A
A
HG21
HD12
ILE
ILE
6
17
1.18
2
A
A
O
H
HIS
ARG
21
25
1.22
2
A
A
O
H
PRO
ALA
15
19
1.33
2
A
A
HA
CD1
ILE
ILE
6
17
1.52
3
A
A
HA
HB2
PHE
LEU
1
5
0.86
3
A
A
HB3
HD3
LEU
PRO
2
3
1.11
3
A
A
O
H
PHE
LEU
1
5
1.19
3
A
A
O
H
PRO
ALA
15
19
1.49
3
A
A
O
N
PHE
LEU
1
5
2.16
3
A
A
OG
O
SER
THR
9
13
2.16
4
A
A
O
H
HIS
ARG
21
25
0.87
4
A
A
HG
O
SER
THR
9
13
1.02
4
A
A
HB3
HD3
LEU
PRO
2
3
1.34
4
A
A
O
H
PRO
ALA
15
19
1.42
4
A
A
O
N
HIS
ARG
21
25
1.71
4
A
A
OG
O
SER
THR
9
13
1.89
5
A
A
HG22
HD13
ILE
ILE
6
17
0.94
5
A
A
HG22
CD1
ILE
ILE
6
17
0.98
5
A
A
O
H
PHE
LEU
1
5
1.13
5
A
A
HG23
HD11
ILE
ILE
6
17
1.16
5
A
A
HG22
HD12
ILE
ILE
6
17
1.21
5
A
A
HA
HD21
PHE
LEU
1
5
1.21
5
A
A
O
H
HIS
ARG
21
25
1.22
5
A
A
O
H
PRO
ALA
15
19
1.27
5
A
A
CG2
HD11
ILE
ILE
6
17
1.51
5
A
A
CG2
CD1
ILE
ILE
6
17
1.79
5
A
A
O
N
PHE
LEU
1
5
2.12
6
A
A
HG23
HD12
ILE
ILE
6
17
1.10
6
A
A
O
H
PRO
ALA
15
19
1.18
6
A
A
O
HG12
LEU
ILE
2
6
1.52
6
A
A
O
N
PRO
ALA
15
19
2.06
7
A
A
O
H
HIS
ARG
21
25
1.28
7
A
A
O
H
PRO
ALA
15
19
1.33
8
A
A
HD2
H
PHE
LEU
1
4
1.12
8
A
A
O
H
SER
THR
9
13
1.45
8
A
A
O
H
HIS
ARG
21
25
1.58
9
A
A
HD2
H
PHE
LEU
1
4
1.28
9
A
A
HB3
HD3
LEU
PRO
2
3
1.30
9
A
A
O
H
PRO
ALA
15
19
1.46
9
A
A
O
H
PRO
LEU
3
7
1.49
9
A
A
O
H
VAL
ILE
16
20
1.58
9
A
A
ND1
NH2
HIS
ARG
21
25
2.12
10
A
A
HB
HG3
ILE
PRO
6
15
0.93
10
A
A
O
H
PHE
LEU
1
5
1.13
10
A
A
HA
HD23
PHE
LEU
1
5
1.20
10
A
A
HD2
NH2
HIS
ARG
21
25
1.46
10
A
A
O
H
PRO
ALA
15
19
1.50
10
A
A
O
HE
HIS
ARG
21
25
1.56
10
A
A
O
H
LEU
GLY
4
8
1.56
10
A
A
CD2
NH2
HIS
ARG
21
25
2.01
10
A
A
O
N
PHE
LEU
1
5
2.12
1
A
LEU
2
-20.69
-58.06
1
A
LEU
11
-127.50
-68.83
1
A
ILE
17
70.59
-52.41
2
A
LEU
2
170.59
-51.00
2
A
LEU
11
-94.72
-64.79
3
A
LEU
2
4.91
-72.18
3
A
LEU
11
58.33
15.42
3
A
MET
12
-148.09
-74.88
4
A
MET
12
-141.52
-61.05
5
A
LEU
2
-18.38
-60.33
6
A
LEU
2
-101.03
-67.40
6
A
LEU
4
86.11
29.37
6
A
LEU
5
-158.93
-49.62
7
A
LEU
2
176.69
-58.83
7
A
LEU
10
-111.21
75.76
7
A
MET
12
-129.93
-55.40
8
A
LEU
2
-104.50
-67.00
8
A
MET
12
-133.65
-60.41
9
A
LEU
2
-106.68
-69.86
9
A
LEU
11
-160.38
-66.37
10
A
LEU
2
-17.09
-61.60
10
A
LEU
10
-96.09
56.10
PONERATOXIN
SOLUTION STRUCTURE OF PONERATOXIN
1
N
N
A
PHE
1
A
PHE
1
HELX_P
A
SER
9
A
SER
9
1
1
9
A
GLN
18
A
GLN
18
HELX_P
A
ARG
25
A
ARG
25
1
2
8
TOXIN
Toxin; Neurotoxin; Sodium channel inhibitor, TOXIN
POTX_PARCV
UNP
1
1
P41736
FLPLLILGSLLMTPPVIQAIHDAQR
1
25
1G92
1
25
P41736
A
1
1
25